25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Sinotherapeutics Inc. A
Buy, Hold or Sell?

Let's analyze Sinotherapeutics together

I guess you are interested in Sinotherapeutics Inc. A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sinotherapeutics Inc. A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sinotherapeutics Inc. A

I send you an email if I find something interesting about Sinotherapeutics Inc. A.

1. Quick Overview

1.1. Quick analysis of Sinotherapeutics (30 sec.)










1.2. What can you expect buying and holding a share of Sinotherapeutics? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
¥2.73
Expected worth in 1 year
¥2.83
How sure are you?
71.4%

+ What do you gain per year?

Total Gains per Share
¥0.10
Return On Investment
0.9%

For what price can you sell your share?

Current Price per Share
¥10.68
Expected price per share
¥8.8274 - ¥13.56
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sinotherapeutics (5 min.)




Live pricePrice per Share (EOD)
¥10.68

2.2. Growth of Sinotherapeutics (5 min.)




Is Sinotherapeutics growing?

Current yearPrevious yearGrowGrow %
How rich?$169.8m$162.4m$4.3m2.6%

How much money is Sinotherapeutics making?

Current yearPrevious yearGrowGrow %
Making money$3.7m$2m$1.7m46.4%
Net Profit Margin24.0%20.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Sinotherapeutics (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sinotherapeutics?

Welcome investor! Sinotherapeutics's management wants to use your money to grow the business. In return you get a share of Sinotherapeutics.

First you should know what it really means to hold a share of Sinotherapeutics. And how you can make/lose money.

Speculation

The Price per Share of Sinotherapeutics is ¥10.68. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sinotherapeutics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sinotherapeutics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.73. Based on the TTM, the Book Value Change Per Share is ¥0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.88 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sinotherapeutics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.000.0%0.010.1%0.010.1%
Usd Book Value Change Per Share0.010.1%0.000.0%0.121.1%0.050.5%0.050.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.1%0.000.0%0.121.1%0.050.5%0.050.5%
Usd Price Per Share1.34-1.28-1.77-1.49-1.49-
Price to Earnings Ratio28.76-43.29-123.17-77.52-77.52-
Price-to-Total Gains Ratio169.45-107.19--66.44-32.77-32.77-
Price to Book Ratio3.57-3.48-4.93-4.10-4.10-
Price-to-Total Gains Ratio169.45-107.19--66.44-32.77-32.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.466364
Number of shares681
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.05
Usd Total Gains Per Share0.000.05
Gains per Quarter (681 shares)2.2636.45
Gains per Year (681 shares)9.02145.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
109-10146136
201880292282
3027170437428
4036260583574
5045350729720
6054440875866
706353010211012
807262011661158
908171013121304
1009080014581450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%5.02.00.071.4%5.02.00.071.4%5.02.00.071.4%5.02.00.071.4%
Dividend per Share0.00.04.00.0%0.00.07.00.0%0.00.07.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share3.01.00.075.0%5.02.00.071.4%5.02.00.071.4%5.02.00.071.4%5.02.00.071.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sinotherapeutics Inc. A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0580.024+138%0.877-93%0.390-85%0.390-85%
Book Value Per Share--2.7292.680+2%2.610+5%2.650+3%2.650+3%
Current Ratio--8.90910.259-13%9.749-9%10.041-11%10.041-11%
Debt To Asset Ratio--0.1350.117+15%0.119+13%0.118+14%0.118+14%
Debt To Equity Ratio--0.1560.133+17%0.135+15%0.134+16%0.134+16%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--4227642822.4104066869287.275+4%5673345677.547-25%4755359168.820-11%4755359168.820-11%
Eps--0.0850.060+40%0.032+162%0.048+75%0.048+75%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--7.3099.452-23%23.525-69%15.483-53%15.483-53%
Free Cash Flow Per Share--0.0010.003-80%0.011-95%0.006-92%0.006-92%
Free Cash Flow To Equity Per Share--0.0010.003-80%0.011-95%0.006-92%0.006-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap4841671200.000+9%4420065000.0004228528850.000+5%5832974666.667-24%4916148485.714-10%4916148485.714-10%
Net Profit Margin--0.2660.240+11%0.203+31%0.224+18%0.224+18%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.1451.198-4%1.333-14%1.256-9%1.256-9%
Pb Ratio3.914+9%3.5733.480+3%4.930-28%4.101-13%4.101-13%
Pe Ratio31.505+9%28.76243.286-34%123.165-77%77.520-63%77.520-63%
Price Per Share10.680+9%9.7509.328+5%12.867-24%10.844-10%10.844-10%
Price To Free Cash Flow Ratio4941.534+9%4511.2321141.048+295%38.378+11655%668.475+575%668.475+575%
Price To Total Gains Ratio185.618+9%169.454107.186+58%-66.441+139%32.774+417%32.774+417%
Quick Ratio--4.9604.661+6%5.005-1%4.808+3%4.808+3%
Return On Assets--0.0270.020+36%0.011+146%0.016+68%0.016+68%
Return On Equity--0.0310.022+38%0.012+150%0.018+71%0.018+71%
Total Gains Per Share--0.0580.024+138%0.877-93%0.390-85%0.390-85%
Usd Book Value--169847152.152166788529.803+2%162485553.767+5%164944397.216+3%164944397.216+3%
Usd Book Value Change Per Share--0.0080.003+138%0.120-93%0.054-85%0.054-85%
Usd Book Value Per Share--0.3750.368+2%0.358+5%0.364+3%0.364+3%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--580455359.517558381153.143+4%778950361.527-25%652910813.879-11%652910813.879-11%
Usd Eps--0.0120.008+40%0.004+162%0.007+75%0.007+75%
Usd Free Cash Flow--33631.332168249.193-80%702214.913-95%397091.644-92%397091.644-92%
Usd Free Cash Flow Per Share--0.0000.000-80%0.002-95%0.001-92%0.001-92%
Usd Free Cash Flow To Equity Per Share--0.0000.000-80%0.002-95%0.001-92%0.001-92%
Usd Market Cap664761455.760+9%606874924.500580577011.105+5%800867421.733-24%674987187.089-10%674987187.089-10%
Usd Price Per Share1.466+9%1.3391.281+5%1.767-24%1.489-10%1.489-10%
Usd Profit--5275016.5503761141.443+40%2017057.734+162%3013676.996+75%3013676.996+75%
Usd Revenue--19855444.41215415877.786+29%9764974.840+103%12994062.238+53%12994062.238+53%
Usd Total Gains Per Share--0.0080.003+138%0.120-93%0.054-85%0.054-85%
 EOD+4 -4MRQTTM+23 -12YOY+15 -205Y+16 -1910Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of Sinotherapeutics Inc. A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.505
Price to Book Ratio (EOD)Between0-13.914
Net Profit Margin (MRQ)Greater than00.266
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.960
Current Ratio (MRQ)Greater than18.909
Debt to Asset Ratio (MRQ)Less than10.135
Debt to Equity Ratio (MRQ)Less than10.156
Return on Equity (MRQ)Greater than0.150.031
Return on Assets (MRQ)Greater than0.050.027
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Sinotherapeutics Inc. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.901
Ma 20Greater thanMa 5010.577
Ma 50Greater thanMa 10010.424
Ma 100Greater thanMa 20010.554
OpenGreater thanClose10.650
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Sinotherapeutics Inc. A

Sinotherapeutics Inc., a specialty pharmaceutical company, develops generic and formulation products in China. It offers posaconazole delayed-release tablets, ursodeoxycholic acid capsules, bupropion hydrochloride extended-release tablets, paroxetine extended-release tablets, sevelamer carbonate tablets, and propafenone hydrochloride extended-release capsules. The company provides CRO/CDMO services including pre-formulation study, formulation and process development, clinical sample manufacturing, NDA registration batch manufacturing, quality standard establishment, and regulatory dossier document preparation and submission. Sinotherapeutics Inc. was founded in 2012 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2025-02-23 11:49:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sinotherapeutics earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 26.6% means that ¥0.27 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sinotherapeutics Inc. A:

  • The MRQ is 26.6%. The company is making a huge profit. +2
  • The TTM is 24.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ26.6%TTM24.0%+2.5%
TTM24.0%YOY20.3%+3.7%
TTM24.0%5Y22.4%+1.6%
5Y22.4%10Y22.4%0.0%
4.3.1.2. Return on Assets

Shows how efficient Sinotherapeutics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.7% Return on Assets means that Sinotherapeutics generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sinotherapeutics Inc. A:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.0%+0.7%
TTM2.0%YOY1.1%+0.9%
TTM2.0%5Y1.6%+0.4%
5Y1.6%10Y1.6%0.0%
4.3.1.3. Return on Equity

Shows how efficient Sinotherapeutics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.1% Return on Equity means Sinotherapeutics generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sinotherapeutics Inc. A:

  • The MRQ is 3.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM2.2%+0.9%
TTM2.2%YOY1.2%+1.0%
TTM2.2%5Y1.8%+0.4%
5Y1.8%10Y1.8%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sinotherapeutics Inc. A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sinotherapeutics is operating .

  • Measures how much profit Sinotherapeutics makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sinotherapeutics Inc. A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Sinotherapeutics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.15 means that the operating costs are ¥1.15 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Sinotherapeutics Inc. A:

  • The MRQ is 1.145. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.198. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.145TTM1.198-0.053
TTM1.198YOY1.333-0.135
TTM1.1985Y1.256-0.058
5Y1.25610Y1.2560.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sinotherapeutics Inc. A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sinotherapeutics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 8.91 means the company has ¥8.91 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Sinotherapeutics Inc. A:

  • The MRQ is 8.909. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.259. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.909TTM10.259-1.350
TTM10.259YOY9.749+0.510
TTM10.2595Y10.041+0.218
5Y10.04110Y10.0410.000
4.4.3.2. Quick Ratio

Measures if Sinotherapeutics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 4.96 means the company can pay off ¥4.96 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sinotherapeutics Inc. A:

  • The MRQ is 4.960. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.661. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.960TTM4.661+0.300
TTM4.661YOY5.005-0.344
TTM4.6615Y4.808-0.147
5Y4.80810Y4.8080.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sinotherapeutics Inc. A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sinotherapeutics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sinotherapeutics to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Sinotherapeutics assets are financed with 13.5% credit (debt) and the remaining percentage (100% - 13.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sinotherapeutics Inc. A:

  • The MRQ is 0.135. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.117. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.135TTM0.117+0.017
TTM0.117YOY0.119-0.002
TTM0.1175Y0.118-0.001
5Y0.11810Y0.1180.000
4.5.4.2. Debt to Equity Ratio

Measures if Sinotherapeutics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 15.6% means that company has ¥0.16 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sinotherapeutics Inc. A:

  • The MRQ is 0.156. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.133. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.156TTM0.133+0.023
TTM0.133YOY0.135-0.002
TTM0.1335Y0.134-0.001
5Y0.13410Y0.1340.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Sinotherapeutics generates.

  • Above 15 is considered overpriced but always compare Sinotherapeutics to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 28.76 means the investor is paying ¥28.76 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sinotherapeutics Inc. A:

  • The EOD is 31.505. Based on the earnings, the company is overpriced. -1
  • The MRQ is 28.762. Based on the earnings, the company is overpriced. -1
  • The TTM is 43.286. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD31.505MRQ28.762+2.743
MRQ28.762TTM43.286-14.524
TTM43.286YOY123.165-79.879
TTM43.2865Y77.520-34.234
5Y77.52010Y77.5200.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sinotherapeutics Inc. A:

  • The EOD is 4,941.534. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 4,511.232. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1,141.048. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4,941.534MRQ4,511.232+430.302
MRQ4,511.232TTM1,141.048+3,370.184
TTM1,141.048YOY38.378+1,102.670
TTM1,141.0485Y668.475+472.573
5Y668.47510Y668.4750.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sinotherapeutics is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Sinotherapeutics Inc. A:

  • The EOD is 3.914. Based on the equity, the company is fair priced.
  • The MRQ is 3.573. Based on the equity, the company is fair priced.
  • The TTM is 3.480. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.914MRQ3.573+0.341
MRQ3.573TTM3.480+0.093
TTM3.480YOY4.930-1.450
TTM3.4805Y4.101-0.622
5Y4.10110Y4.1010.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,429,474
Total Liabilities192,422
Total Stockholder Equity1,237,051
 As reported
Total Liabilities 192,422
Total Stockholder Equity+ 1,237,051
Total Assets = 1,429,474

Assets

Total Assets1,429,474
Total Current Assets1,001,125
Long-term Assets428,349
Total Current Assets
Cash And Cash Equivalents 297,636
Short-term Investments 450,000
Net Receivables 107,413
Inventory 107,253
Other Current Assets 8,788
Total Current Assets  (as reported)1,001,125
Total Current Assets  (calculated)971,090
+/- 30,034
Long-term Assets
Property Plant Equipment 280,537
Goodwill 18,386
Intangible Assets 22,509
Long-term Assets Other 24,652
Long-term Assets  (as reported)428,349
Long-term Assets  (calculated)346,084
+/- 82,265

Liabilities & Shareholders' Equity

Total Current Liabilities112,372
Long-term Liabilities80,050
Total Stockholder Equity1,237,051
Total Current Liabilities
Accounts payable 21,751
Other Current Liabilities 1,411
Total Current Liabilities  (as reported)112,372
Total Current Liabilities  (calculated)23,163
+/- 89,210
Long-term Liabilities
Long-term Liabilities  (as reported)80,050
Long-term Liabilities  (calculated)0
+/- 80,050
Total Stockholder Equity
Retained Earnings 282,522
Total Stockholder Equity (as reported)1,237,051
Total Stockholder Equity (calculated)282,522
+/- 954,529
Other
Capital Stock453,340
Common Stock Shares Outstanding 453,340
Net Invested Capital 1,237,051
Net Working Capital 888,752
Property Plant and Equipment Gross 280,537



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-31
> Total Assets 
1,328,875
1,347,278
1,353,037
1,361,620
1,353,289
1,361,353
1,429,474
1,429,4741,361,3531,353,2891,361,6201,353,0371,347,2781,328,875
   > Total Current Assets 
950,917
957,104
949,229
952,009
945,451
945,125
1,001,125
1,001,125945,125945,451952,009949,229957,104950,917
       Cash And Cash Equivalents 
449,794
382,114
141,813
641,784
229,423
267,009
297,636
297,636267,009229,423641,784141,813382,114449,794
       Short-term Investments 
328,000
415,000
642,000
0
509,000
481,000
450,000
450,000481,000509,0000642,000415,000328,000
       Net Receivables 
33,389
34,361
42,666
65,919
73,499
71,260
107,413
107,41371,26073,49965,91942,66634,36133,389
       Inventory 
34,622
68,500
59,084
84,609
80,950
80,953
107,253
107,25380,95380,95084,60959,08468,50034,622
       Other Current Assets 
63,407
17,212
12,226
127,121
10,843
7,400
8,788
8,7887,40010,843127,12112,22617,21263,407
   > Long-term Assets 
377,957
390,174
403,809
409,612
407,838
416,228
428,349
428,349416,228407,838409,612403,809390,174377,957
       Property Plant Equipment 
256,555
258,162
260,484
271,405
270,217
272,009
280,537
280,537272,009270,217271,405260,484258,162256,555
       Goodwill 
18,386
18,386
18,386
18,386
18,386
18,386
18,386
18,38618,38618,38618,38618,38618,38618,386
       Intangible Assets 
30,826
29,246
27,709
27,591
25,865
24,164
22,509
22,50924,16425,86527,59127,70929,24630,826
       Long-term Assets Other 
5,018
10,636
13,134
12,535
13,062
19,216
24,652
24,65219,21613,06212,53513,13410,6365,018
> Total Liabilities 
143,898
175,255
159,734
151,361
152,469
150,386
192,422
192,422150,386152,469151,361159,734175,255143,898
   > Total Current Liabilities 
81,291
115,330
102,602
90,717
95,140
80,814
112,372
112,37280,81495,14090,717102,602115,33081,291
       Short Long Term Debt 
327
220
62
63
63
54
0
054636362220327
       Accounts payable 
13,208
17,026
14,244
14,527
13,850
18,343
21,751
21,75118,34313,85014,52714,24417,02613,208
       Other Current Liabilities 
964
2,245
1,626
1,908
1,956
819
1,411
1,4118191,9561,9081,6262,245964
   > Long-term Liabilities 
62,607
59,925
57,131
60,644
57,329
69,571
80,050
80,05069,57157,32960,64457,13159,92562,607
       Capital Lease Obligations Min Short Term Debt
1,117
747
38
22
7
0
0
00722387471,117
> Total Stockholder Equity
1,184,976
1,172,024
1,193,303
1,210,259
1,200,820
1,210,967
1,237,051
1,237,0511,210,9671,200,8201,210,2591,193,3031,172,0241,184,976
   Common Stock0000000
   Retained Earnings 
196,102
183,056
204,351
219,593
242,489
255,331
282,522
282,522255,331242,489219,593204,351183,056196,102
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 0000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue299,871
Cost of Revenue-132,265
Gross Profit167,606167,606
 
Operating Income (+$)
Gross Profit167,606
Operating Expense-247,214
Operating Income52,657-79,608
 
Operating Expense (+$)
Research Development74,005
Selling General Administrative14,021
Selling And Marketing Expenses0
Operating Expense247,21488,027
 
Net Interest Income (+$)
Interest Income6,078
Interest Expense-38
Other Finance Cost-57
Net Interest Income5,983
 
Pretax Income (+$)
Operating Income52,657
Net Interest Income5,983
Other Non-Operating Income Expenses0
Income Before Tax (EBT)65,99152,657
EBIT - interestExpense = -38
61,074
61,112
Interest Expense38
Earnings Before Interest and Taxes (EBIT)066,029
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax65,991
Tax Provision-4,917
Net Income From Continuing Ops61,07461,074
Net Income61,074
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-5,983
 

Technical Analysis of Sinotherapeutics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sinotherapeutics. The general trend of Sinotherapeutics is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sinotherapeutics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sinotherapeutics Inc. A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11.09 < 13.21 < 13.56.

The bearish price targets are: 9.41 > 8.8374 > 8.8274.

Tweet this
Sinotherapeutics Inc. A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sinotherapeutics Inc. A. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sinotherapeutics Inc. A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sinotherapeutics Inc. A. The current macd is 0.11211796.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinotherapeutics price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sinotherapeutics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sinotherapeutics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sinotherapeutics Inc. A Daily Moving Average Convergence/Divergence (MACD) ChartSinotherapeutics Inc. A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sinotherapeutics Inc. A. The current adx is 23.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sinotherapeutics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Sinotherapeutics Inc. A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sinotherapeutics Inc. A. The current sar is 10.52.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sinotherapeutics Inc. A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sinotherapeutics Inc. A. The current rsi is 52.90. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Sinotherapeutics Inc. A Daily Relative Strength Index (RSI) ChartSinotherapeutics Inc. A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sinotherapeutics Inc. A. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -1/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sinotherapeutics price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Sinotherapeutics Inc. A Daily Stochastic Oscillator ChartSinotherapeutics Inc. A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sinotherapeutics Inc. A. The current cci is 49.17.

Sinotherapeutics Inc. A Daily Commodity Channel Index (CCI) ChartSinotherapeutics Inc. A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sinotherapeutics Inc. A. The current cmo is 4.62995273.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sinotherapeutics Inc. A Daily Chande Momentum Oscillator (CMO) ChartSinotherapeutics Inc. A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sinotherapeutics Inc. A. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sinotherapeutics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sinotherapeutics Inc. A Daily Williams %R ChartSinotherapeutics Inc. A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sinotherapeutics Inc. A.

Sinotherapeutics Inc. A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sinotherapeutics Inc. A. The current atr is 0.34589256.

Sinotherapeutics Inc. A Daily Average True Range (ATR) ChartSinotherapeutics Inc. A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sinotherapeutics Inc. A. The current obv is 117,733,254.

Sinotherapeutics Inc. A Daily On-Balance Volume (OBV) ChartSinotherapeutics Inc. A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sinotherapeutics Inc. A. The current mfi is 55.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sinotherapeutics Inc. A Daily Money Flow Index (MFI) ChartSinotherapeutics Inc. A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sinotherapeutics Inc. A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Sinotherapeutics Inc. A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sinotherapeutics Inc. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.901
Ma 20Greater thanMa 5010.577
Ma 50Greater thanMa 10010.424
Ma 100Greater thanMa 20010.554
OpenGreater thanClose10.650
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sinotherapeutics with someone you think should read this too:
  • Are you bullish or bearish on Sinotherapeutics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sinotherapeutics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sinotherapeutics Inc. A

I send you an email if I find something interesting about Sinotherapeutics Inc. A.


Comments

How you think about this?

Leave a comment

Stay informed about Sinotherapeutics Inc. A.

Receive notifications about Sinotherapeutics Inc. A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.